RNA Virus Infections  >>  tenofovir disoproxil fumarate  >>  Phase 3
Welcome,         Profile    Billing    Logout  

18 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tenofovir disoproxil fumarate / Generic mfg.
NCT00158821: Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.

Completed
3
180
US
Viread (tenofovir disoproxil fumarate), Viread, Sustiva (Efavirenz), Sustiva, Epivir (Lamivudine), Epivir, Zerit (Stavudine) Placebo, Zerit
Gilead Sciences
HIV Infections
12/01
06/13
NCT00117676 / 2004-005119-27: A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B

Completed
3
382
US, Canada, Europe, RoW
TDF, Viread®, ADV, Hepsera®, TDF placebo, ADV placebo, FTC/TDF, Truvada®
Gilead Sciences
Chronic Hepatitis B
04/07
01/16
NCT00116805 / 2004-005120-41: A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B

Completed
3
266
US, Canada, Europe, RoW
TDF, Viread®, ADV, Hepsera®, TDF placebo, ADV placebo, FTC/TDF, Truvada®
Gilead Sciences
Chronic Hepatitis B
05/07
01/16
KALEAD, NCT00234910 / 2004-000786-35: Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Completed
3
152
US
Tenofovir DF, lopinavir/ritonavir with 2 Nucleoside RTIs, ABT-378, Kaletra, lopinavir/ritonavir
Abbott
HIV Infection
06/07
06/08
NCT00352053 / 2015-000727-85: Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral Therapy

Completed
3
87
RoW
Tenofovir DF, Placebo
Gilead Sciences
HIV Infections
09/08
12/13
NCT00528957 / 2007-003418-32: Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children

Completed
3
97
US, Europe, RoW
Tenofovir DF, Viread®, Zidovudine, Stavudine
Gilead Sciences
HIV Infections
04/09
08/17
NCT00805675: Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB

Completed
3
83
RoW
Telbivudine, Tenofovir, Telbivudine plus tenofovir
Novartis Pharmaceuticals
Hepatitis B Virus
12/10
 
DEFINE, NCT00410202: Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus

Completed
3
629
US, Canada, Europe, RoW
Entecavir, Baraclude, BMS-200475, Tenofovir, Viread, Adefovir, Hepsera, Lamivudine, Epivir
Bristol-Myers Squibb
Hepatitis B, Chronic
01/11
07/12
NCT00734162 / 2007-003704-35: Evaluation of Tenofovir Disoproxil Fumarate in Adolescents With Chronic Hepatitis B Infection

Completed
3
106
US, Europe, RoW
Tenofovir disoproxil fumarate (TDF), Viread®, Placebo
Gilead Sciences
Hepatitis B Virus (HBV)
03/11
12/15
NCT01300234: Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB)

Completed
3
512
RoW
Tenofovir disoproxil fumarate (TDF) tablets, TDF tablet, Adefovir dipivoxil (ADV) tablets, ADV tablet
GlaxoSmithKline
Hepatitis B
10/12
12/16
NCT01063036 / 2009-015705-40: Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous Treatment

Completed
3
144
Europe
Entecavir, Baraclude®, BMS-200475, Tenofovir, Viread®
Bristol-Myers Squibb
Chronic Hepatitis B
11/12
02/14
NCT01480284: Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue

Completed
3
166
Japan
GSK548470 300 mg tablet, GSK548470, ETV 0.5 mg capsule, ETV
GlaxoSmithKline
Hepatitis B, Chronic
01/13
11/14
NCT01821794: Tenofovir DF With or Without Peginterferon for Chronic Hepatitis B

Active, not recruiting
3
26
US
Peginterferon and Tenofovir
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Chronic Hepatitis B e Antigen Negative, Chronic Hepatitis B e Antigen Positive
03/13
12/17
NCT01475851: Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs

Completed
3
34
Japan
GSK548470 300 mg tablet, GSK548470
GlaxoSmithKline
Hepatitis B, Chronic
06/13
10/14
NCT01872988: Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma

Terminated
3
320
RoW
Tenofovir, Viread, Placebo
Taichung Veterans General Hospital, Gilead Sciences, Taipei Institute of Pathology
Chronic Hepatitis B, Hepatocellular Carcinoma
02/18
02/18
NCT00111150: Botswana Tenofovir Oral HIV Prophylaxis Trial

Terminated
2/3
1200
US, RoW
Tenofovir Disoproxil Fumarate 300 mg daily
Centers for Disease Control and Prevention, Botswana Ministry of Health, Gilead Sciences
HIV Infection
 
03/07
NCT00624195: Clinical Trial of CNS-targeted HAART (CIT2)

Completed
2/3
59
US
FDA Approved Antiretroviral Therapy (see list below), Atripla, Combivir, Emtriva, Epivir, Epzicom, Retrovir, Trizivir, Truvada, Viread, Ziagen, Intelence, Rescriptor, Sustiva, Viramune, Agenerase, Aptivus, Invirase, Kaletra, Lexiva, Norvir, Prezista, Reyataz, Viracept, Fuzeon, Selzentry, Isentress
University of California, San Diego, National Institutes of Health (NIH), National Institute of Mental Health (NIMH)
HIV Infections
02/12
06/12
NCT00078182: Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia

Withdrawn
2/3
0
RoW
Tenofovir DF
National Institute of Allergy and Infectious Diseases (NIAID), NCHADS - Ministry of Health of Cambodia, Kirby Institute
HIV Infections, HIV Seronegativity
 
 

Download Options